Immunomodulanti in Urologia. II. Effetti a Livello Sistemico Della Somministrazione Intravescicale Del Bacillo Di Calmette-Guérin (Bcg) Nel Carcinoma Della Vescica

Abo T. , Balch C.M. : A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J. Immunol., 127; 1024 (1981).

Althausen A.F. , Prout G.R. Jr. , Daly J.J. : Noninvasive papillary carcinoma of the bladder associated with carcinoma in situ. J. Urol., 116; 575 (1976).

Altman L.C. , Snyderman R. , Hausman M.S. , Mergenhagen S.E. : A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by autologous leukocytes. J. Immunol., 110; 801 (1973).

Antonaci S. , Bonomo L. : Effetti in vitro e in vivo degli immunomodulanti. In: Immunologia Clinica del Fegato e del Rene. Immunoterapia. Recenti progressi, Fradà G. (ed.), p. 395, Piccin Editore, Padova 1983.

Antonaci S. , Brandonisio O. , Ventura M.T. , Serlenga E. , Sansone L. , Bonomo L. : Leukocyte inhibitory factor production by human peripheral blood lymphomonocytes stimulated with lipopolysaccharides from smooth and rough Salmonella strains. IRCS Med. Sci., 13; 261 (1985).

Antonaci S. , Gallitelli M. , Jirillo E. : Lymphocyte-derived chemotactic factor is produced by peripheral blood OKT8⁺ lymphocytes lacking Ml antigen. IRCS Med. Sci., 14; 1011 (1986).

Antonaci S. , Jirillo E. , Silvestris F. , Lucivero G. , Fumarola D. , Bonomo L. : In vitro modulation of cell-mediated immunity by Prostaglandin E₂. I. Enhancing-inhibitory effects on antibody-dependent cellular cytotoxicity. Prostaglandins Leuk. Med., 9; 285 (1982).

Antonaci S. , Piccinno A. , Lucivero G. , Miglietta A. , Piccininno A. , Bonomo L. : Effect of BCG immunotherapy on cell-mediated cytotoxicity in bladder cancer patients following surgical treatment. Tumori, 67; 177 (1981).

Antonaci S. , Ventura M.T. , Jirillo E. , Piccinno A. : Citotossicità cellulo-mediata nel carcinoma della vescica. Urologia, 50; 457 (1983).

Badalament R.A. , Herr H.W. , Wong G.Y. , Gnecco C. , Pinsky C.M. , Whitemore W.F. , Fair W.R. , Oettgen H.F. : A prospective randomized trial of maintenance versus non-maintenance intravesical Bacillus Calmette-Guérin therapy of superficial bladder cancer. J. Clin. Oncol., 5; 441 (1987).

Böyum A. : Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest., 21; Suppl. 97, 77 (1968).

Braun D.P. , Harris J.E. : Serial immune functions testing to predict clinical disease relapse in patients with solid tumors. Cancer Immunol. Immunother., 15; 165 (1983).

Broder S. : Cellular regulation of immune function. J. Allergy Clin. Immunol., 65; 239 (1980).

Broder S. , Waldman T.A. : The suppressor cell network in cancer. N. Engl. J. Med., 299; 1281 (1978).

Brosman S.A. : Experience with Bacillus Calmette-Guérin in patients with superficial bladder carcinoma. J. Urol., 128; 27 (1982).

Brosman S. , Elhilali M. , Vescera C. , Fahey J. : Immune response in bladder cancer patients. J. Urol., 121; 162 (1979).

Clausen J.E. : Migration inhibition of human leukocytes mixed with phytohemagglutinin-preincubated mononuclear leukocytes. Acta Allergol., 30; 239 (1975).

Clement L.T. , Dagg M.K. , Landay A. : Characterization of human lymphocyte subpopulations: alloreactive cytotoxic T lymphocyte precursor and effector cells are phenotypically distinct from Leu 2⁺ suppressor cells. J. Clin. Immunol., 4; 395 (1984a).

Clement L.T. , Grossi C.E. , Gartland G.L. : Morphological and phenotypic features of the subpopulation of Leu-2 ⁺ cells that suppresses B cell differentiation. J. Immunol., 133; 2461 (1984b).

Droller M.J. : Immunotherapy in genitourinary neoplasia. Urol. Clin. N. Amer., 11; 643 (1984).

Droller M.J. : Bacillus Calmette-Guérin in the management of bladder cancer. J. Urol., 135; 231 (1986).

Fleischmann J.D. , Toossi Z. , Ellner J.J. , Wentworth D.B. , Rafliff T.L. , Imbembo A.L. : Urinary interleukins in patients receiving intravesical Bacillus Calmette-Guérin therapy for superficial bladder cancer. Cancer, 64; 1447 (1989).

Guinan P. , McKiel C. , Flanagan M. , Bhatti R. , Pessis D. , Ablin R.J. : Cellular immunity in bladder cancer patients. J. Urol., 119; 747 (1978).

Hanna M.G. Jr. , Snodgrass M.J. , Zbar B. , Rapp H.J. : Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG. J. Natl. Cancer Inst., 51; 1897 (1973).

Herr H.W. , Pinsky C.M. , Whitemore W.F. , Oettgen H.F. , Melamed M.R. : Effect of intravesical Bacillus Calmette-Guérin (BCG) on carcinoma in situ of the bladder. Cancer, 51; 1323 (1983).

Hoffmann M.K. : Antigen-specific induction and regulation of antibody synthesis in cultures of human peripheral blood mononuclear cells. Proc. Natl. Acad. Sci. USA, 77; 1139 (1980).

Jirillo E. , Antonaci S. , Bonomo L. : Effects of Prostaglandin E₂ on immunoglobulin synthesis. Boll. Ist. Sieroter. Milanese, 62; 301 (1983).

Koontz W.W. Jr. , Prout G.R. Jr. , Smith W. , Frable W.G. , Minnis J.E. : The use of intravesical tiotepa in the management of non-invasive carcinoma of the bladder. J. Urol., 125; 307 (1981).

Kunori T. , Broman P. , Tan M. : Spontaneous antibody-secreting human blood lymphocytes detected with a protein A plaque assay. Clin. Exp. Immunol., 42; 162 (1980).

Lamm D.L. : Bacillus Calmette-Guérin immunotherapy for bladder cancer. J. Urol., 134; 40 (1985).

Lamm D.L. , Thor D.E. , Stogdill W.D. , Radwin H.M. : Bladder cancer immunotherapy. J. Urol., 128; 931 (1982).

Lamm D.L. , Thor D.E. , Winters W.D. , Stogdill V.D. , Radwin H.M. : BCG immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses. Cancer, 48; 82 (1981).

Larsson A. , Näslund I. , Troye M. : A follow-up study of urinary bladder patients tested for tumor-related lymphocyte-mediated cytotoxicity. Cancer Immunol. Immunother., 14; 82 (1982).

Morales A. , Eidinger D. , Bruce A.W. : Intracavitary Bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J. Urol., 116; 180 (1976).

Nelson D.S. , Nelson M. , Farram E. , Inoue Y. : Cancer and subversion of host defences. Austr. J. Exp. Biol. Med. Sci., 59; 229 (1981).

O'Toole C. , Perlmann P. , Unsgaard B. , Almgard L.E. , Johansson B. , Moberger G. , Edsmyr F. : Cellular immunity to human urinary bladder carcinoma. II. Effect of surgery and preoperative irradiation. Intern. J. Cancer, 10; 92 (1972).

Reinherz E.L. , Moretta L. , Roper M. , Breard J.M. , Mingari M.C. , Cooper M.D. , Schlossman S.F. : Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J. Exp. Med., 151; 969 (1980).

Silvestris F. , Antonaci S. , Lucivero G. , Piccinno A. , Bonomo L. : Fenomeni citotossici nel carcinoma della vescica. Linfociti, interazione delle IgG autologhe e significato prognostico. Rec. Prog. Med., 72; 531 (1982).

Snyderman R. , Altman L.C. , Hausman M.S. , Mergenhagen S.E. : Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factor. J. Immunol., 108; 857 (1972).

Tokunaga T. , Kataoka T. , Nakamura R.M. , Yamamoto S. : Akagawa K.S.: Mode of antitumor action of BCG. GANN, Monograph. Cancer Res., 21; 59 (1978).

Torti F.M. , Lum B.L. : Superficial carcinoma of the bladder: natural history and the role of interferons. Semin. Oncol., 13; Suppl. 2, 57 (1986).

Troye M. , Hannson Y. , Paulie S. , Perlmann P. , Blomgren H. , Johansson B. : Lymphocyte mediated lysis of tumor cells in vitro (ADCC) induced by serum antibodies from patients with urinary bladder carcinoma or controls. Intern. J. Cancer, 25; 45 (1980).

Troye M. , Perlmann P. , Larsson A. , Blomgren H. , Johansson B. : Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: ⁵¹Cr-release assay. Intern. J. Cancer, 20; 188 (1977).

Unger S.W. , Bernhard M.I. , Pace R.C. , Wanebo H.J. : Monocyte dysfunction in human cancer. Cancer, 51; 669 (1983).

Union Internationale Contre le Cancer: Classification of malignant tumors. UICC, Geneva 1974.

Winters W.D. , Lamm D.L. : Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients. Cancer Res., 41; 2672 (1981).

Yam L.T. , Li C.Y. , Crosby M.H. : Cytochemical identification of monocytes and granulocytes. Amer. J. Clin. Pathol., 55; 283 (1971).